
Study Period | 2019 - 2030 |
Market Size (2025) | USD 24.56 Billion |
Market Size (2030) | USD 35.79 Billion |
CAGR (2025 - 2030) | 7.82 % |
Fastest Growing Market | Europe |
Largest Market | North America |
Market Concentration | High |
Major Players![]() *Disclaimer: Major Players sorted in no particular order |
Blood Glucose Monitoring Market Analysis
The Global Blood Glucose Monitoring Market size is estimated at USD 24.56 billion in 2025, and is expected to reach USD 35.79 billion by 2030, at a CAGR of 7.82% during the forecast period (2025-2030).
The blood glucose monitoring industry is experiencing significant transformation driven by the escalating global diabetes epidemic. According to recent estimates published by The Lancet in 2023, over 1.31 billion individuals worldwide are projected to be affected by diabetes by 2050, representing an unprecedented challenge for healthcare systems globally. Type 2 diabetes currently accounts for approximately 90% of all diabetes cases, with social risk factors including high BMI, dietary risks, and low physical activity levels being primary contributors. This dramatic increase in prevalence has catalyzed substantial investments in glucose monitoring technologies and healthcare infrastructure development worldwide.
Technological innovation is revolutionizing the blood glucose monitoring landscape through the integration of advanced connectivity features and data analytics capabilities. Modern monitoring systems are increasingly incorporating cellular connectivity and secure cloud-based databases, enabling seamless data sharing between patients and healthcare providers. These technological advancements are facilitating more precise blood glucose measurement and management of blood glucose levels, while also enabling healthcare providers to offer more personalized treatment plans based on comprehensive data analysis.
The healthcare industry is witnessing a paradigm shift in diabetes management approaches, with an increasing focus on preventive care and early intervention strategies. Remote monitoring programs are becoming more sophisticated, allowing healthcare providers to offer timely support and interventions based on real-time blood sugar monitoring data. This evolution in care delivery is particularly significant as it enables healthcare systems to manage the growing diabetes population more effectively while potentially reducing the burden on traditional healthcare infrastructure.
The market is experiencing rapid advancement in device miniaturization and user-friendly design, making blood sugar monitoring more accessible and convenient for patients. Manufacturers are focusing on developing innovative features such as improved accuracy, faster reading times, and enhanced data visualization capabilities. The integration of artificial intelligence and machine learning algorithms is enabling predictive analytics and personalized insights, helping patients and healthcare providers make more informed decisions about diabetes management strategies. These developments are particularly significant as they address the growing demand for more efficient and user-friendly monitoring solutions in both developed and emerging markets. Leading glucose monitoring companies are at the forefront of these innovations, driving the market forward with cutting-edge solutions.
Blood Glucose Monitoring Market Trends
Rising Prevalence of Diabetes and Growing Need for Regular Monitoring
The escalating diabetes epidemic continues to drive the blood glucose monitoring market, with recent statistics highlighting the critical need for effective monitoring solutions. According to the Centers for Disease Control and Prevention (CDC) National Diabetes Statistics Report 2022, more than 130 million adults are living with diabetes or prediabetes in the United States alone. This substantial patient population, combined with increasing awareness about the importance of regular glucose monitoring, creates a strong foundation for market growth. The situation is particularly consequential among communities of color, rural populations, and those with lower health literacy and income levels, emphasizing the need for accessible monitoring solutions.
The growing focus on social determinants of health (SDOH) by major medical organizations has further highlighted the critical need for blood glucose monitoring. The American Diabetes Association, along with other prestigious medical organizations like the Endocrine Society and the American College of Physicians, has published comprehensive scientific reviews describing the associations between SDOH and diabetes risk and outcomes. These reviews specifically examine factors such as socioeconomic status, health literacy, food environment, food insecurity, and neighborhood environments, demonstrating the complex nature of diabetes management and the essential role of regular monitoring in improving patient outcomes.
Technological Advancements in Monitoring Devices
The blood glucose monitoring devices market is experiencing significant growth driven by continuous technological innovations that enhance user experience and monitoring accuracy. Recent developments include the introduction of advanced CGM models such as the Abbott Freestyle Libre 3 and the Dexcom G7, which have successfully overcome previous technical barriers and improved the overall monitoring experience. These technological improvements have significantly enhanced healthcare providers' ability to treat diabetes while simultaneously empowering patients to better manage their blood glucose levels through more sophisticated yet user-friendly devices.
The integration of digital health applications with blood glucose monitoring devices represents another significant technological advancement driving market growth. These innovative solutions now offer capabilities to display and summarize individual blood glucose measurements while incorporating additional relevant data such as insulin doses, meals/snacks, and physical activity levels. For instance, in January 2023, LifeScan published a groundbreaking study in the Journal of Diabetes Science and Technology demonstrating improved glycemic control through the use of Bluetooth-connected blood glucose meters and mobile diabetes apps, based on real-world data from over 144,000 diabetes patients. The integration of blood glucose monitoring with insulin calculators, automated insulin titration software, and remote coaching capabilities provides additional support for patients with poorly controlled diabetes, further driving market expansion.
Supportive Healthcare Guidelines and Insurance Coverage
The market is significantly influenced by supportive international guidelines that recommend regular self-monitoring of blood glucose (SMBG) for effective diabetes management and treatment. These guidelines, coupled with increasing insurance coverage for monitoring devices, particularly CGMs, are creating a more favorable environment for market growth. The Centre for Health Care Strategies has provided strong evidence supporting the benefits of CGM use for all insulin-treated patients, whether using insulin pumps or multiple daily insulin injections, leading to expanded coverage policies and increased accessibility for patients.
The healthcare system's growing recognition of the importance of blood glucose monitoring has led to improved reimbursement policies and coverage options. Medical institutions increasingly acknowledge that while there may be minor discrepancies between blood glucose meter readings and laboratory testing results, the immediate results provided by monitoring devices offer crucial advantages in terms of convenience and timely intervention. This recognition has resulted in the widespread adoption of blood glucose monitoring devices across various healthcare settings, from home care to hospital emergency rooms, supported by favorable coverage policies that make these essential devices more accessible to a broader patient population.
Enhanced Patient Convenience and Self-Management Capabilities
The growing emphasis on patient autonomy and self-management capabilities has become a significant driver in the blood glucose device market. Modern monitoring devices now offer real-time glucose readings and trend analysis, enabling patients to make immediate decisions about their diabetes management. The integration of these devices with comprehensive diabetes management platforms has revolutionized the way patients interact with their health data, offering features such as automated data logging, pattern recognition, and personalized insights that support more effective self-management strategies.
The development of user-friendly interfaces and pain-reducing technologies has significantly enhanced patient acceptance and compliance with regular monitoring. Advanced digital platforms now incorporate additional functionalities such as automated insulin titration, meal planning, and physical activity tracking, providing a more holistic approach to diabetes management. The ability to share data with healthcare providers in real-time and receive remote coaching has further improved the quality of care while reducing the burden on both patients and healthcare systems. These convenience features, combined with the integration of artificial intelligence and machine learning capabilities, are creating more sophisticated yet accessible monitoring solutions that encourage regular use and better health outcomes.
Segment Analysis: Self-Monitoring Blood Glucose Devices
Test Strips Segment in Blood Glucose Self-Monitoring Devices Market
Test strips dominate the blood glucose monitoring devices market, commanding approximately 78% of the total market share in 2024. This significant market position is attributed to the essential nature of test strips in regular blood glucose monitoring, as they are single-use components that require frequent replacement. The segment's dominance is further strengthened by the increasing diabetic population globally and the growing awareness about the importance of regular blood glucose monitoring. Healthcare providers and insurance companies have also played a crucial role in maintaining the segment's leadership by ensuring consistent coverage and reimbursement policies for test strips, recognizing their fundamental role in diabetes management. The segment has also benefited from technological advancements that have improved the accuracy and reliability of test strips, making them an indispensable component of modern diabetes care.

Glucometer Devices Segment in Blood Glucose Self-Monitoring Devices Market
The blood glucose meter devices segment is experiencing the most rapid growth in the blood glucose self-monitoring devices market, with an expected growth rate of approximately 8% during 2024-2029. This accelerated growth is driven by continuous technological innovations in blood glucose meter design, including improved accuracy, faster results, and enhanced connectivity features. The integration of smart technology, including Bluetooth connectivity and mobile app synchronization, has made these devices more appealing to tech-savvy users. Additionally, the development of more user-friendly interfaces and compact designs has increased their adoption among elderly patients and those new to blood glucose monitoring. The segment's growth is further supported by increasing healthcare digitalization and the rising trend of home healthcare monitoring, particularly in developing regions where awareness about diabetes management is rapidly increasing.
Remaining Segments in Self-Monitoring Blood Glucose Devices
The lancets segment completes the self-monitoring blood glucose devices market triad, playing a vital role in the blood glucose monitoring process. Lancets serve as the primary tool for obtaining blood samples and are essential companions to both glucometers and test strips. The segment has witnessed steady development with innovations focusing on minimizing pain and improving safety features. Modern lancets now incorporate advanced technologies such as precision tip designs and depth adjustment capabilities, enhancing the overall user experience. The segment has also seen improvements in terms of materials used and disposal mechanisms, addressing both safety and environmental concerns. Manufacturers continue to focus on developing lancets that provide optimal blood flow while minimizing discomfort, making them an integral part of the complete blood glucose monitoring system.
Segment Analysis: Continuous Blood Glucose Monitoring Devices
Sensors Segment in Continuous Blood Glucose Monitoring Devices Market
The sensors segment dominates the global continuous glucose monitoring devices market, commanding approximately 85% of the total market share in 2024. This significant market position is attributed to the recurring nature of sensor purchases, as they need to be replaced every 7-14 days depending on the manufacturer's specifications. The segment's dominance is further strengthened by the increasing adoption of CGM systems among both Type 1 and Type 2 diabetes patients, particularly in developed markets like North America and Europe. Major manufacturers have focused on developing more accurate and longer-lasting sensors, with improved features such as better accuracy, longer wear time, and enhanced connectivity with smartphones and other devices. The segment has also benefited from favorable reimbursement policies in key markets and increasing awareness about the benefits of continuous glucose monitoring over traditional finger-stick methods.
Durables Segment in Continuous Blood Glucose Monitoring Devices Market
The durables segment, which includes transmitters and receivers, is projected to grow at approximately 17% during the forecast period 2024-2029, making it the fastest-growing segment in the continuous glucose monitoring devices market. This accelerated growth is driven by technological advancements in transmitter design, including improved battery life, enhanced data transmission capabilities, and better integration with insulin delivery systems. The segment is witnessing increased innovation in terms of device miniaturization, improved water resistance, and extended battery life, making the devices more user-friendly and convenient for long-term use. The growth is further supported by the rising adoption of integrated diabetes management systems and the increasing preference for connected devices that can seamlessly share data with healthcare providers and caregivers. Manufacturers are also focusing on developing more cost-effective durable components to make CGM systems more accessible to a broader patient population.
Global Blood Glucose Monitoring Market Geography Segment Analysis
Blood Glucose Monitoring Market in North America
North America represents a highly developed blood glucose monitoring market, characterized by advanced healthcare infrastructure and high adoption rates of both self-monitoring and continuous glucose monitoring systems. The region benefits from extensive insurance coverage, well-established diabetes care protocols, and a strong presence of major market players. The United States and Canada are the key markets, with significant investments in research and development of innovative monitoring technologies. The region's blood glucose monitoring market is driven by increasing diabetes prevalence, growing awareness about the importance of regular glucose monitoring, and continuous technological advancements in monitoring devices.

Blood Glucose Monitoring Market in United States
The United States dominates the North American blood glucose monitoring market, leveraging its sophisticated healthcare system and extensive network of diabetes care centers. The country's market is characterized by high adoption rates of both traditional and advanced glucose monitoring devices, supported by favorable reimbursement policies and strong healthcare infrastructure. The American Diabetes Association plays a crucial role in enhancing public awareness regarding diabetes and supporting research and development operations. The United States holds approximately 52% of the global market share in 2024, reflecting its position as the largest blood glucose monitoring market worldwide. The country's market is driven by factors such as the high prevalence of diabetes, increasing obesity rates, and continuous technological innovations in monitoring devices.
Blood Glucose Monitoring Market in Canada
Canada represents one of the fastest-growing markets in North America, with significant developments in both self-monitoring and continuous glucose monitoring segments. The country's healthcare system provides comprehensive coverage for diabetes management, supporting the adoption of advanced monitoring technologies. The market growth is supported by increasing diabetes awareness, government initiatives for diabetes management, and growing adoption of advanced monitoring systems. Canada is expected to register a growth rate of approximately 12% during 2024-2029, driven by expanding access to innovative monitoring technologies and increasing focus on preventive healthcare measures. The country's market benefits from strong distribution networks and a growing emphasis on personalized diabetes care solutions.
Blood Glucose Monitoring Market in Europe
Europe represents a sophisticated blood glucose monitoring market, characterized by well-established healthcare systems and comprehensive diabetes care protocols. The region demonstrates strong adoption of both traditional and advanced monitoring systems, supported by favorable reimbursement policies and high healthcare standards. Key markets include Germany, France, the United Kingdom, Italy, Spain, and Russia, each contributing significantly to the regional market dynamics. The European market benefits from strong research and development activities, continuous technological innovations, and an increasing focus on personalized diabetes care solutions.
Blood Glucose Monitoring Market in Germany
Germany leads the European blood glucose monitoring market, supported by its advanced healthcare infrastructure and comprehensive diabetes care programs. The country's market is characterized by high adoption rates of innovative monitoring technologies and a strong presence of major market players. According to the German Diabetes Centre, the country has implemented various initiatives to improve diabetes care and management. Germany accounts for approximately 32% of the European market share in 2024, reflecting its dominant position in the region. The market benefits from extensive insurance coverage and a strong emphasis on technological advancement in diabetes care.
Blood Glucose Monitoring Market in Spain
Spain emerges as the fastest-growing market in Europe, demonstrating significant advancements in diabetes care and monitoring technologies. The country has witnessed the emergence of several startups focused on providing innovative solutions for controlling diabetes spread and reducing prevalence rates. Spain is expected to register a growth rate of approximately 12% during 2024-2029, driven by increasing awareness about diabetes management and growing adoption of advanced monitoring systems. The market benefits from strong healthcare infrastructure and comprehensive national health service systems that support diabetes care and management.
Blood Glucose Monitoring Market in Latin America
Latin America represents an emerging blood glucose monitoring market, with significant growth potential across various countries. The region faces unique challenges in healthcare accessibility and affordability, yet demonstrates increasing adoption of both traditional and advanced monitoring systems. Brazil leads the market in terms of size, while Mexico shows promising growth potential. The region's market is characterized by increasing diabetes awareness, growing healthcare expenditure, and improving access to advanced monitoring technologies. Healthcare systems in Latin America are working to address the challenge of increasing prevalence of chronic diseases, including diabetes, while managing budget constraints.
Blood Glucose Monitoring Market in Brazil
Brazil dominates the Latin American blood glucose monitoring market, supported by its large population base and improving healthcare infrastructure. The country has implemented significant reforms to improve the distribution of medical services and develop new forms of service organizations. The Brazilian Health System (SUS) has progressively increased assistance available for individuals with diabetes, though supply challenges persist across various cities. The market benefits from increasing awareness about diabetes management and growing adoption of advanced monitoring technologies.
Blood Glucose Monitoring Market in Mexico
Mexico demonstrates strong growth potential in the blood glucose monitoring market, driven by increasing diabetes prevalence and improving healthcare infrastructure. The country has implemented various initiatives to enhance diabetes care and management, including digital approaches through platforms like CHKT. The Mexican Diabetes Federation actively collaborates with healthcare service providers to improve patient care. The market shows promising development in both self-monitoring and continuous glucose monitoring segments.
Blood Glucose Monitoring Market in Asia-Pacific
The Asia-Pacific region represents a diverse and rapidly evolving blood glucose monitoring market, encompassing both developed and emerging economies. The region includes major markets such as Japan, China, India, Australia, and several Southeast Asian countries. China leads the regional market in terms of size, while Indonesia demonstrates the fastest growth rate. The market is characterized by increasing diabetes prevalence, growing healthcare expenditure, and improving access to advanced monitoring technologies across various countries. The region shows significant potential for market expansion, driven by large population bases, increasing awareness about diabetes management, and improving healthcare infrastructure.
Blood Glucose Monitoring Market in Middle East & Africa
The Middle East & Africa region presents a growing blood glucose monitoring market, with varying levels of healthcare infrastructure and accessibility across countries. The region encompasses diverse markets including Saudi Arabia, Iran, Egypt, Oman, and South Africa, each with unique healthcare dynamics and challenges. Saudi Arabia emerges as the largest market in the region, while Iran shows the fastest growth potential. The market is characterized by increasing diabetes prevalence, growing healthcare awareness, and improving access to monitoring technologies, particularly in the Gulf Cooperation Council countries.
Blood Glucose Monitoring Industry Overview
Top Companies in Blood Glucose Monitoring Market
The blood glucose monitoring market features prominent players like Abbott, Roche, LifeScan, Dexcom, Medtronic, and Ascensia leading innovation and market development. Companies are increasingly focusing on developing advanced continuous glucose monitoring systems with enhanced accuracy and connectivity features, particularly integrating IoT and cloud computing capabilities. Strategic partnerships between major manufacturers are driving technological advancement, especially in developing seamless diabetes care platforms that combine glucose sensing with automated insulin delivery systems. The industry is witnessing a significant shift towards smart healthcare solutions, with companies investing in wireless medical appliances and big data analytics. Market leaders are expanding their global presence through distribution networks and online platforms, while simultaneously working on cost-effective solutions to penetrate emerging markets.
Consolidated Market with Strong Regional Players
The blood glucose monitoring market exhibits a unique structure with distinct characteristics in its self-monitoring and continuous glucose monitoring segments. The self-monitoring segment remains highly fragmented with a strong presence of local players, particularly in developing regions where price sensitivity drives market dynamics. Global conglomerates dominate the continuous glucose monitoring market segment, leveraging their advanced technological capabilities and extensive research infrastructure. These companies maintain their market position through substantial investments in research and development, patent protection, and strategic acquisitions of innovative startups.
The market demonstrates active merger and acquisition activity, particularly focused on acquiring innovative technologies and expanding geographical presence. Major players are increasingly pursuing vertical integration strategies, controlling everything from manufacturing to distribution channels. The competitive landscape is further shaped by the emergence of startup companies bringing novel technologies to market, particularly in areas such as non-invasive glucose monitoring and integrated diabetes management platforms. Regional players maintain significant market share in their respective territories through strong distribution networks and understanding of local healthcare systems.
Innovation and Accessibility Drive Future Success
Success in the blood glucose monitoring market increasingly depends on balancing technological innovation with accessibility and affordability. Incumbent companies must focus on developing user-friendly blood glucose monitoring devices with enhanced connectivity features while maintaining cost competitiveness to protect their market share. The ability to provide comprehensive diabetes management solutions, rather than standalone monitoring devices, is becoming crucial. Companies need to invest in building strong relationships with healthcare providers and insurance companies to ensure favorable reimbursement policies, while also expanding their direct-to-consumer channels.
For contenders looking to gain market share, focusing on underserved markets and specific user segments presents significant opportunities. Success factors include developing specialized products for specific demographic groups, establishing strong distribution partnerships, and leveraging digital platforms for market penetration. The regulatory environment continues to evolve, particularly around data privacy and accuracy standards, requiring companies to maintain robust compliance frameworks. The threat of substitution remains moderate, primarily from emerging non-invasive monitoring technologies, pushing companies to continuously innovate while maintaining competitive pricing strategies. End-user concentration varies by region, with institutional buyers having significant bargaining power in developed markets, while individual consumers drive demand in emerging economies.
Blood Glucose Monitoring Market Leaders
-
Abbott Diabetes Care
-
Roche Holding AG
-
Medtronic PLC
-
Dexcom Inc.
-
LifeScan Inc.
- *Disclaimer: Major Players sorted in no particular order

Blood Glucose Monitoring Market News
- October 2023: The Canadian government approved Dexcom's next-generation Dexcom G7 Continuous Glucose Monitoring System for Canadian type-1 diabetes patients.
- June 2023: The initial locally-produced continuous glucose monitoring device was granted approval by the South Korean Ministry of Food and Drug Safety. I-SENS, the manufacturer of blood glucose devices, introduced CareSens Air, which claimed to be the most compact and lightweight CGM device accessible in South Korea. Additionally, it has the capability to be utilized continuously for a period of 15 days and incorporates a calibration mechanism to enhance the accuracy of readings.
Global Blood Glucose Monitoring Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
- 4.2 Market Drivers
- 4.3 Market Restraints
-
4.4 Industry Attractiveness - Porter's Five Forces Analysis
- 4.4.1 Bargaining Power of Suppliers
- 4.4.2 Bargaining Power of Consumers
- 4.4.3 Threat of New Entrants
- 4.4.4 Threat of Substitute Products and Services
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
-
5.1 By Device (Revenue and Volume)
- 5.1.1 Self-Monitoring Blood Glucose
- 5.1.1.1 Glucometer Devices
- 5.1.1.2 Test Strips
- 5.1.1.3 Lancets
- 5.1.2 Continuous Glucose Monitoring
- 5.1.2.1 Sensors
- 5.1.2.2 Durables (Receivers and Transmitters)
-
5.2 By End User (Revenue and Volume)
- 5.2.1 Hospital/Clinics Usage
- 5.2.2 Self/Home Usage
-
5.3 By Indicators (Revenue and Volume)
- 5.3.1 Type-1 Diabetes Population
- 5.3.2 Type-2 Diabetes Population
-
5.4 Geography (Revenue and Volume)
- 5.4.1 North America
- 5.4.1.1 By Device, By End User, By Indicators
- 5.4.1.2 By Country
- 5.4.1.2.1 United States
- 5.4.1.2.2 Canada
- 5.4.1.2.3 Rest of North America
- 5.4.2 Europe
- 5.4.2.1 By Device, By End User, By Indicators
- 5.4.2.2 By Country
- 5.4.2.2.1 France
- 5.4.2.2.2 Germany
- 5.4.2.2.3 Italy
- 5.4.2.2.4 Spain
- 5.4.2.2.5 United Kingdom
- 5.4.2.2.6 Russia
- 5.4.2.2.7 Rest of Europe
- 5.4.3 Latin America
- 5.4.3.1 By Device, By End User, By Indicators
- 5.4.3.2 By Country
- 5.4.3.2.1 Mexico
- 5.4.3.2.2 Brazil
- 5.4.3.2.3 Rest of Latin America
- 5.4.4 Asia-Pacific
- 5.4.4.1 By Device, By End User, By Indicators
- 5.4.4.2 By Country
- 5.4.4.2.1 Japan
- 5.4.4.2.2 South Korea
- 5.4.4.2.3 China
- 5.4.4.2.4 India
- 5.4.4.2.5 Australia
- 5.4.4.2.6 Vietnam
- 5.4.4.2.7 Malaysia
- 5.4.4.2.8 Indonesia
- 5.4.4.2.9 Philippines
- 5.4.4.2.10 Thailand
- 5.4.4.2.11 Rest of Asia-Pacific
- 5.4.5 Middle East and Africa
- 5.4.5.1 By Device, By End User, By Indicators
- 5.4.5.2 By Country
- 5.4.5.2.1 Saudi Arabia
- 5.4.5.2.2 Iran
- 5.4.5.2.3 Egypt
- 5.4.5.2.4 Oman
- 5.4.5.2.5 South Africa
- 5.4.5.2.6 Rest of Middle East and Africa
6. MARKET INDICATORS
- 6.1 Type-1 Diabetes population
- 6.2 Type-2 Diabetes population
7. COMPETITIVE LANDSCAPE
-
7.1 COMPANY PROFILES
- 7.1.1 Abbott Diabetes Care
- 7.1.2 Roche Holding AG
- 7.1.3 LifeScan
- 7.1.4 Dexcom Inc.
- 7.1.5 Medtronic PLC
- 7.1.6 Arkray Inc.
- 7.1.7 Ascensia Diabetes Care
- 7.1.8 Agamatrix Inc.
- 7.1.9 Bionime Corporation
- 7.1.10 Acon Laboratories Inc.
- 7.1.11 Medisana AG
- 7.1.12 Trivida Functional Medicine
- 7.1.13 Rossmax International Ltd
- 7.1.14 Sinocare
- 7.1.15 Senseonics
- *List Not Exhaustive
-
7.2 COMPANY SHARE ANALYSIS
- 7.2.1 Self-monitoring Blood Glucose
- 7.2.1.1 Abbott Diabetes Care
- 7.2.1.2 Roche Holding AG
- 7.2.1.3 LifeScan
- 7.2.1.4 Others
- 7.2.2 Continuous Glucose Monitoring Devices
- 7.2.2.1 Abbott Diabetes Care
- 7.2.2.2 Dexcom Inc.
- 7.2.2.3 Medtronic PLC
- 7.2.2.4 Others
8. MARKET OPPORTUNITIES AND FUTURE TRENDS
Blood Glucose Monitoring Industry Segmentation
Blood glucose monitoring devices are used to diagnose both hyperglycemic and hypoglycemic conditions in diabetic patients. The Report Covers the Blood Glucose Monitoring Devices Market Dynamics & Growth. The Market is Segmented by Device (Self-monitoring Blood Glucose (Glucometer Devices, Test Strips, and Lancets) and Continuous Glucose Monitoring (Sensors and Durables (Receivers and Transmitters)), End User (Hospital/Clinical Usage and Home/Personal Usage), Indicators (Type-1 Diabetes Population and Type-2 Diabetes Population) and by Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America). The Report Offers the Value (in USD) and Volume (in Units) for the Above Segments.
By Device (Revenue and Volume) | Self-Monitoring Blood Glucose | Glucometer Devices | ||
Test Strips | ||||
Lancets | ||||
Continuous Glucose Monitoring | Sensors | |||
Durables (Receivers and Transmitters) | ||||
By End User (Revenue and Volume) | Hospital/Clinics Usage | |||
Self/Home Usage | ||||
By Indicators (Revenue and Volume) | Type-1 Diabetes Population | |||
Type-2 Diabetes Population | ||||
Geography (Revenue and Volume) | North America | By Device, By End User, By Indicators | ||
By Country | United States | |||
Canada | ||||
Rest of North America | ||||
Europe | By Device, By End User, By Indicators | |||
France | ||||
Germany | ||||
Italy | ||||
Spain | ||||
United Kingdom | ||||
Russia | ||||
Rest of Europe | ||||
Latin America | By Device, By End User, By Indicators | |||
Mexico | ||||
Brazil | ||||
Rest of Latin America | ||||
Asia-Pacific | By Device, By End User, By Indicators | |||
Japan | ||||
South Korea | ||||
China | ||||
India | ||||
Australia | ||||
Vietnam | ||||
Malaysia | ||||
Indonesia | ||||
Philippines | ||||
Thailand | ||||
Rest of Asia-Pacific | ||||
Middle East and Africa | By Device, By End User, By Indicators | |||
Saudi Arabia | ||||
Iran | ||||
Egypt | ||||
Oman | ||||
South Africa | ||||
Rest of Middle East and Africa |
Global Blood Glucose Monitoring Market Research Faqs
How big is the Global Blood Glucose Monitoring Market?
The Global Blood Glucose Monitoring Market size is expected to reach USD 24.56 billion in 2025 and grow at a CAGR of 7.82% to reach USD 35.79 billion by 2030.
What is the current Global Blood Glucose Monitoring Market size?
In 2025, the Global Blood Glucose Monitoring Market size is expected to reach USD 24.56 billion.
Who are the key players in Global Blood Glucose Monitoring Market?
Abbott Diabetes Care, Roche Holding AG, Medtronic PLC, Dexcom Inc. and LifeScan Inc. are the major companies operating in the Global Blood Glucose Monitoring Market.
Which is the fastest growing region in Global Blood Glucose Monitoring Market?
Europe is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Global Blood Glucose Monitoring Market?
In 2025, the North America accounts for the largest market share in Global Blood Glucose Monitoring Market.
What years does this Global Blood Glucose Monitoring Market cover, and what was the market size in 2024?
In 2024, the Global Blood Glucose Monitoring Market size was estimated at USD 22.64 billion. The report covers the Global Blood Glucose Monitoring Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Global Blood Glucose Monitoring Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Our Best Selling Reports
Global Blood Glucose Monitoring Market Research
Mordor Intelligence provides a comprehensive analysis of the blood glucose monitoring market. Our expertise in the glucose monitoring industry enables us to deliver in-depth research. The report examines the evolving landscape of blood glucose monitoring devices and systems. This includes both traditional blood glucose meters and advanced continuous glucose monitoring devices. The analysis covers crucial BGM industry trends, offering detailed insights into glucose monitoring companies and their innovative solutions. These range from basic blood glucose measurement tools to sophisticated continuous glucose monitoring systems.
Stakeholders gain valuable insights through our extensive analysis of the blood glucose dataset. The report is available in an easy-to-read PDF format for download. Our comprehensive coverage includes a detailed examination of SMBG systems, developments in point of care glucose testing, and emerging non-invasive glucose monitoring devices. Our research provides strategic intelligence on blood glucose device innovations and glucose monitoring market size projections. Additionally, it covers technological advancements in diabetes monitoring devices. This enables businesses to make informed decisions in this rapidly evolving sector.